NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OncoPep, Inc.

OncoPep, Inc.

Private
North Andover, MassachusettsHealthcare & Life Scienceshttps://oncopep.com

Last Round

Series D

Dec 9, 2021

Total Funding Raised

$17.9M

Company Overview

OncoPep, Inc. is a biotechnology company that develops targeted peptide-based cancer vaccines and immunotherapeutics for the treatment of multiple myeloma and other cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic cancer vaccinecancer immunotherapyimmunotherapyimmuno-oncologycancer vaccinemulti-peptide vaccinepeptide therapeuticsadoptive T cell therapyT cell therapytriple-negative breast cancermultiple myeloma treatmentbiotech drug discoveryclinical-stage biotechcomputational drug designprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoPep, Inc. Comps

Public and private peers based on sector, stage, and business model.

OncoPep, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoPep, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DDec 9, 2021
Series BAug 28, 2014
VC RoundApr 26, 2012

OncoPep, Inc. Investors

Notable investors and investment history

OncoPep, Inc. investors
InvestorRounds
Leukemia & Lymphoma SocietySeries B

OncoPep, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoPep, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoPep, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNorth Andover, Massachusetts
Employee Range4
Year Founded2010
Last FundingDec 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.